JULIA KORSUNSKY: Open Payments
NPI 1164605762 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,989 in 139 payments from 16 companies in 2025. Trend: 2023 $2,786 · 2024 $2,177 · 2025 $2,989
Food & beverage: $2,877Education: $113
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $516 |
| Otsuka America Pharmaceutical, Inc. | 23 | $440 |
| Axsome Therapeutics, Inc. | 17 | $439 |
| Lundbeck LLC | 13 | $271 |
| Janssen Pharmaceuticals, Inc | 7 | $261 |
| Vanda Pharmaceuticals Inc. | 13 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $163 |
| ABBVIE INC. | 11 | $153 |
| Teva Pharmaceuticals USA, Inc. | 2 | $132 |
| Collegium Pharmaceutical, Inc. | 4 | $89 |
Products named: REXULTI, CAPLYTA, Auvelity, HETLIOZ, TRINTELLIX, ABILIFY ASIMTUFII, VRAYLAR, SPRAVATO.
Industry payments across CA — which companies pay providers there.
